Piramal Enterprises Limited (PEL.NS)
INR 967.75
(2.1%)
INR 967.75
(2.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 491.39 Billion INR | 7.33% |
| 2022 | 457.81 Billion INR | -7.07% |
| 2021 | 492.62 Billion INR | 45.58% |
| 2020 | 338.38 Billion INR | -10.71% |
| 2019 | 378.97 Billion INR | -31.37% |
| 2018 | 552.17 Billion INR | 32.2% |
| 2017 | 417.69 Billion INR | 44.19% |
| 2016 | 289.67 Billion INR | 82.83% |
| 2015 | 158.44 Billion INR | 126.86% |
| 2014 | 69.84 Billion INR | -24.31% |
| 2013 | 92.26 Billion INR | 24.36% |
| 2012 | 74.19 Billion INR | 362.32% |
| 2011 | 16.04 Billion INR | 258.36% |
| 2010 | -10.13 Billion INR | -180.83% |
| 2009 | 12.53 Billion INR | 0.74% |
| 2008 | 12.44 Billion INR | 88.21% |
| 2007 | 6.61 Billion INR | 12.33% |
| 2006 | 5.88 Billion INR | 172.32% |
| 2005 | 2.16 Billion INR | -38.68% |
| 2004 | 3.52 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 555.89 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 491.39 Billion INR | 0.0% |
| 2023 FY | 491.39 Billion INR | 7.33% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 470.02 Billion INR | 0.0% |
| 2022 Q2 | 438.33 Billion INR | 0.0% |
| 2022 Q4 | 457.81 Billion INR | 12.55% |
| 2022 FY | 457.81 Billion INR | -7.07% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | 406.77 Billion INR | -7.2% |
| 2021 Q4 | 492.62 Billion INR | 0.0% |
| 2021 Q2 | 559.31 Billion INR | 0.0% |
| 2021 FY | 492.62 Billion INR | 45.58% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 338.38 Billion INR | -10.71% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 274.79 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 338.38 Billion INR | 0.0% |
| 2019 FY | 378.97 Billion INR | -31.37% |
| 2019 Q2 | 332.83 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 378.97 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 410.02 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 552.17 Billion INR | 0.0% |
| 2018 FY | 552.17 Billion INR | 32.2% |
| 2017 Q2 | 322.2 Billion INR | 0.0% |
| 2017 Q3 | 377.56 Billion INR | 17.18% |
| 2017 Q4 | 417.69 Billion INR | 10.63% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 417.69 Billion INR | 44.19% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 289.67 Billion INR | 82.83% |
| 2016 Q4 | 289.67 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 260.97 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 158.44 Billion INR | 126.86% |
| 2015 Q4 | 158.44 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 59.89 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 69.84 Billion INR | 0.0% |
| 2014 FY | 69.84 Billion INR | -24.31% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 33.87 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 85.24 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 92.26 Billion INR | 24.36% |
| 2013 Q4 | 92.26 Billion INR | 0.0% |
| 2012 FY | 74.19 Billion INR | 362.32% |
| 2012 Q4 | 74.19 Billion INR | 0.0% |
| 2012 Q3 | - INR | 100.0% |
| 2012 Q2 | -1.7 Billion INR | 0.0% |
| 2011 Q4 | 16.04 Billion INR | 0.0% |
| 2011 FY | 16.04 Billion INR | 258.36% |
| 2010 FY | -10.13 Billion INR | -180.83% |
| 2009 FY | 12.53 Billion INR | 0.74% |
| 2008 FY | 12.44 Billion INR | 88.21% |
| 2007 FY | 6.61 Billion INR | 12.33% |
| 2006 FY | 5.88 Billion INR | 172.32% |
| 2005 FY | 2.16 Billion INR | -38.68% |
| 2004 FY | 3.52 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -12610.916% |
| Hester Biosciences Limited | 2.29 Billion INR | -21351.204% |
| Aarti Drugs Limited | 5.54 Billion INR | -8756.451% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -18713.557% |
| Albert David Limited | -278.36 Million INR | 176625.151% |
| Alembic Limited | 66.9 Million INR | -734416.143% |
| Alkem Laboratories Limited | -1.6 Billion INR | 30632.577% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -213610.646% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -14795.362% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 2664045.029% |
| Brooks Laboratories Limited | 49.48 Million INR | -992910.609% |
| Eris Lifesciences Limited | 13.8 Billion INR | -3459.158% |
| FDC Limited | -57.75 Million INR | 850964.559% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 17386.32% |
| Gufic Biosciences Limited | 3.19 Billion INR | -15283.298% |
| Hikal Limited | 7.96 Billion INR | -6067.834% |
| Ind-Swift Limited | 9.5 Billion INR | -5067.868% |
| Innova Captab Limited | 2.33 Billion INR | -20955.777% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 44719.205% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 35453.672% |
| Jubilant Pharmova Limited | 27.07 Billion INR | -1715.127% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 385088.248% |
| Lupin Limited | 19.38 Billion INR | -2434.918% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -50257.221% |
| Medico Remedies Limited | 78.67 Million INR | -624467.917% |
| Morepen Laboratories Limited | -231.17 Million INR | 212663.394% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -7880.626% |
| Orchid Pharma Limited | -1.31 Billion INR | 37501.01% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 21028.079% |
| RPG Life Sciences Limited | -364.7 Million INR | 134838.497% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -409259.708% |
| Sigachi Industries Limited | 859.94 Million INR | -57041.912% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | -4798.336% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -338846.653% |
| Themis Medicare Limited | 764.96 Million INR | -64137.348% |
| Unichem Laboratories Limited | 931.91 Million INR | -52629.141% |
| Vaishali Pharma Limited | 119.13 Million INR | -412365.942% |
| Wanbury Limited | 1.1 Billion INR | -44334.615% |
| Windlas Biotech Limited | -273.04 Million INR | 180070.444% |
| ZIM Laboratories Limited | 983.6 Million INR | -49858.245% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 11932.044% |
| Ipca Laboratories Limited | 11.41 Billion INR | -4204.71% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 778.061% |
| Venus Remedies Limited | -267.7 Million INR | 183660.441% |
| Sakar Healthcare Limited | 790.93 Million INR | -62027.742% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -13204.939% |
| Divi's Laboratories Limited | -39.77 Billion INR | 1335.583% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 9903.433% |
| Mankind Pharma Limited | -1.74 Billion INR | 28205.987% |
| Sequent Scientific Limited | 4.17 Billion INR | -11659.627% |
| Laurus Labs Limited | 24.35 Billion INR | -1917.413% |
| Neuland Laboratories Limited | -214.05 Million INR | 229659.886% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -17317.812% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 11567.013% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -12461.127% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 197610.893% |
| Wockhardt Limited | 18.27 Billion INR | -2589.608% |
| Bal Pharma Limited | 1.26 Billion INR | -38789.401% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -3705.4% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 42543.572% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 134162.487% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 9021.897% |
| Shilpa Medicare Limited | 9.06 Billion INR | -5318.045% |
| Valiant Laboratories Limited | 649.9 Million INR | -75510.061% |
| Ajanta Pharma Limited | -954.9 Million INR | 51559.975% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -165029.552% |
| Granules India Limited | 9.28 Billion INR | -5191.293% |
| Medicamen Biotech Limited | 160.31 Million INR | -306414.197% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -1063264.35% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | -1443.799% |
| NATCO Pharma Limited | -5.81 Billion INR | 8547.504% |
| Suven Life Sciences Limited | -1.63 Billion INR | 30196.889% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -25322.213% |
| Strides Pharma Science Limited | 23.25 Billion INR | -2012.876% |
| Indoco Remedies Limited | 6.47 Billion INR | -7487.531% |
| Alpa Laboratories Limited | 35.36 Million INR | -1389463.385% |
| Lasa Supergenerics Limited | 205.79 Million INR | -238672.443% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 52275.759% |